Grade 4 Pneumonitis in a Patient Treated with a Combination of Gemcitabine and Docetaxel for Recurrent Leiomyosarcoma of the Uterus
Gemcitabine and docetaxel combination chemotherapy is the standard of care for patients with unresectable recurrent or metastatic leiomyosarcoma of the uterus. Although they are generally well-tolerated agents, they can also cause severe and life-threatening pulmonary toxicities. Here, we describe a...
Saved in:
Main Authors: | Connor Wang (Author), Stephen Rose (Author), Lori Mankowski Gettle (Author), Ryan Spencer (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Docetaxel-related interstitial pneumonitis
by: Wang CJ, et al.
Published: (2015) -
Solitary CNS Metastasis on Initial Presentation of High Grade Serous Carcinoma of the Fallopian Tube
by: Felicity Harl, et al.
Published: (2018) -
Gemcitabine induced pneumonitis: a case report and review of literature
by: Nishanth Thalambedu, et al.
Published: (2020) -
Gemcitabine and docetaxel combination chemotherapy induced dermatomyositis associated with hand-foot syndrome
by: Mayuko Kawada, et al.
Published: (2021) -
Myxoid Leiomyosarcoma of the Uterus in a Fertile Woman
by: Vito Leanza, et al.
Published: (2017)